Skip Navigation



Europace Advance Access published online on September 21, 2007

Europace, doi:10.1093/europace/eum196
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
9/11/1099    most recent
eum196v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kolettis, T. M.
Right arrow Articles by Pantos, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolettis, T. M.
Right arrow Articles by Pantos, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats

Theofilos M. Kolettis1,*, Maria G. Agelaki1, Giannis G. Baltogiannis1, Antonios P. Vlahos2, Iordanis Mourouzis3, Andreas Fotopoulos4 and Constantinos Pantos3

1 Department of Cardiology, University of Ioannina, 1 Stavrou Niarxou Avenue, 45110 Ioannina, Greece; 2 Department of Child Health, University of Ioannina, 1 Stavrou Niarxou Avenue, 45110 Ioannina, Greece; 3 Department of Pharmacology, University of Athens, Goudi, Athens, Greece; 4 Department of Nuclear Medicine, University of Ioannina, 1 Stavrou Niarxou Avenue, 45110 Ioannina, Greece

Aims: This study investigated whether chronic and acute amiodarone treatment has differential effects on ventricular arrhythmogenesis during acute myocardial infarction in rats.

Methods and results: Forty-six rats were randomly allocated into vehicle, chronic oral amiodarone (30 mg/kg daily for 2 weeks), or acute amiodarone (a single dose, 100 mg/kg). Five additional rats were sham-operated. Myocardial infarction was generated by left coronary artery ligation 2 weeks after chronic treatment. Amiodarone was administered acutely 5 min post-ligation. The electrocardiogram was recorded for 24 h, using an implanted telemetry transmitter. Episodes of ventricular tachyarrhythmias and mortality rates were analysed. Serum catecholamines and infarct size were measured 24 h post-ligation. No differences were found in infarct size. Compared with controls (22.7 ± 10.9), there was a similar reduction in the number of tachyarrhythmia episodes after either chronic (2.6 ± 1.6, P = 0.0011) or acute (3.6 ± 1.7, P = 0.031) amiodarone administration. Norepinephrine levels were lower only after chronic treatment. Mortality in both amiodarone treatment arms was exclusively due to bradyarrhythmia secondary to cardiac failure, whereas mortality in controls was mainly attributed to tachyarrhythmic death.

Conclusions: A rapid antiarrhythmic effect was observed after acute amiodarone administration in the rat. Norepinephrine levels decreased after chronic treatment and may be associated with bradyarrhythmic mortality.

Key Words: Myocardial infarction, Ventricular tachyarrhythmias, Amiodarone, Loading dosage, Catecholamines, Mortality


* Corresponding author. Tel: +30 2651097227; fax: +30 2651097053. E-mail address: thkolet{at}cc.uoi.gr

Manuscript submitted 6 July 2007. Accepted after revision 13 August 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.